Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐chain Amyloidosis
2018 ◽
Vol 45
(3)
◽
pp. 505-522
◽
2020 ◽
Vol 42
(1)
◽
pp. 157-174.e4
◽
2016 ◽
Vol 56
(12)
◽
pp. 1591-1602
◽
2015 ◽
Vol 73
(3)
◽
pp. 780-789
◽